• Investing Ideas
  • /
  • Australian Pharmaceuticals & Biotech Potentially Undervalued Companies
Header cover image

Australian Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED May 16, 2024

Companies with a Value score of at least 3, ordered by Value score

39 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MVP

Medical Developments International		AU$0.42-5.6%-46.2%AU$37.1mAU$3.57PS1.1xE82.7%0%

TRJ

Trajan Group Holdings		AU$0.9935.8%-28.9%AU$150.7mAU$1.16PB1.2xE77.4%n/a

LGP

Little Green Pharma		AU$0.13-7.1%-27.8%AU$39.2mn/aPS1.7xE46.0%n/a

LGP

Little Green Pharma		AU$0.13-3.7%-25.7%AU$39.2mn/aPS1.7xE46.0%n/a

BDX

BCAL Diagnostics		AU$0.1118.3%23.6%AU$27.8mn/aPS7.5xE60.0%n/a

AVH

AVITA Medical		US$2.50-8.1%-31.1%US$211.6mUS$7.09PS4.2xE60.2%n/a

AVH

AVITA Medical		US$2.48-8.5%-31.7%US$211.6mUS$7.03PS4.2xE60.2%n/a

MVP

Medical Developments International		AU$0.43-3.4%-44.9%AU$37.1mAU$3.66PS1.1xE82.7%0%

TRJ

Trajan Group Holdings		AU$0.9935.6%-29.3%AU$150.7mAU$1.15PB1.2xE77.4%n/a

MSB

Mesoblast		AU$1.03-6.8%-11.3%AU$1.2bAU$1.10PS104.6xE56.8%n/a

IMM

Immutep		AU$0.44-5.9%23.9%AU$517.1mn/aPS131.6xE19.5%n/a

MYXDA

Mayne Pharma Group		AU$3.47-9.4%n/aAU$305.4mAU$5.17PB0.5xE73.5%0%

IMM

Immutep		AU$0.43-6.5%20.8%AU$517.1mn/aPS131.6xE19.5%n/a

ACR

Acrux		AU$0.062-1.6%40.9%AU$18.0mn/aPS1.6xE115.3%0%

NEU

Neuren Pharmaceuticals		AU$21.8012.9%50.4%AU$2.8bAU$26.13PE17.7xE0.8%n/a

KZA

Kazia Therapeutics		AU$0.08-27.3%-19.2%AU$18.9mn/aPS34068.4xE49.6%n/a

ARX

Aroa Biosurgery		AU$0.50-2.0%-47.4%AU$172.1mAU$1.01PS2.9xE114.9%n/a

ARX

Aroa Biosurgery		AU$0.50-1.5%-46.8%AU$172.1mAU$1.01PS2.9xE114.9%n/a

ACR

Acrux		AU$0.062-3.1%29.2%AU$18.0mn/aPS1.6xE115.3%0%

BDX

BCAL Diagnostics		AU$0.1118.3%23.6%AU$27.8mn/aPS7.5xE60.0%n/a

NEU

Neuren Pharmaceuticals		AU$21.8513.5%50.7%AU$2.8bAU$26.19PE17.7xE0.8%n/a

VIT

Vitura Health		AU$0.1012.9%-68.2%AU$60.5mn/aPE6.4xn/a9.5%

KZA

Kazia Therapeutics		AU$0.08-27.3%-17.5%AU$18.9mn/aPS34068.4xE49.6%n/a

MYXDA

Mayne Pharma Group		AU$3.54-9.2%n/aAU$305.4mAU$5.28PB0.5xE73.5%0%
Page 1 of 2
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.